Perspective Therapeutics (CATX) Current Assets (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Current Assets for 15 consecutive years, with $148.4 million as the latest value for Q4 2025.
- Quarterly Current Assets fell 35.81% to $148.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $148.4 million through Dec 2025, down 35.81% year-over-year, with the annual reading at $148.4 million for FY2025, 35.81% down from the prior year.
- Current Assets hit $148.4 million in Q4 2025 for Perspective Therapeutics, down from $178.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $294.2 million in Q2 2024 to a low of $16.8 million in Q4 2023.
- Historically, Current Assets has averaged $116.5 million across 5 years, with a median of $66.1 million in 2021.
- Biggest five-year swings in Current Assets: plummeted 68.36% in 2023 and later surged 1272.93% in 2024.
- Year by year, Current Assets stood at $63.6 million in 2021, then decreased by 16.33% to $53.2 million in 2022, then plummeted by 68.36% to $16.8 million in 2023, then soared by 1272.93% to $231.2 million in 2024, then crashed by 35.81% to $148.4 million in 2025.
- Business Quant data shows Current Assets for CATX at $148.4 million in Q4 2025, $178.5 million in Q3 2025, and $196.0 million in Q2 2025.